Literature DB >> 33922558

Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.

Ezequiel Monferrer1,2, Isaac Vieco-Martí1, Amparo López-Carrasco1,2, Fernando Fariñas3, Sergio Abanades4,5, Luis de la Cruz-Merino6, Rosa Noguera1,2, Tomás Álvaro Naranjo2,7,8.   

Abstract

A comprehensive view of cell metabolism provides a new vision of cancer, conceptualized as tissue with cellular-altered metabolism and energetic dysfunction, which can shed light on pathophysiological mechanisms. Cancer is now considered a heterogeneous ecosystem, formed by tumor cells and the microenvironment, which is molecularly, phenotypically, and metabolically reprogrammable. A wealth of evidence confirms metabolic reprogramming activity as the minimum common denominator of cancer, grouping together a wide variety of aberrations that can affect any of the different metabolic pathways involved in cell physiology. This forms the basis for a new proposed classification of cancer according to the altered metabolic pathway(s) and degree of energy dysfunction. Enhanced understanding of the metabolic reprogramming pathways of fatty acids, amino acids, carbohydrates, hypoxia, and acidosis can bring about new therapeutic intervention possibilities from a metabolic perspective of cancer.

Entities:  

Keywords:  tumor ecosystem; tumor microenvironment; tumor reprogramming

Year:  2021        PMID: 33922558     DOI: 10.3390/metabo11050264

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  174 in total

Review 1.  Fatty acid synthase as a potential therapeutic target in cancer.

Authors:  Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.

Authors:  Lisa S Pike; Amy L Smift; Nicole J Croteau; David A Ferrick; Min Wu
Journal:  Biochim Biophys Acta       Date:  2011-06

Review 3.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

4.  Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.

Authors:  Jian Chen; Sulin Zhang; Yuncheng Li; Zhengang Tang; Weijia Kong
Journal:  Tumour Biol       Date:  2013-12-21

5.  Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.

Authors:  R S Brown; R L Wahl
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

Review 6.  Carbotoxicity-Noxious Effects of Carbohydrates.

Authors:  Guido Kroemer; Carlos López-Otín; Frank Madeo; Rafael de Cabo
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

Review 7.  Engineered diets to improve cancer outcomes.

Authors:  Marcus D Goncalves; Oliver Dk Maddocks
Journal:  Curr Opin Biotechnol       Date:  2020-11-21       Impact factor: 10.279

Review 8.  The Diverse Functions of Non-Essential Amino Acids in Cancer.

Authors:  Bo-Hyun Choi; Jonathan L Coloff
Journal:  Cancers (Basel)       Date:  2019-05-15       Impact factor: 6.639

9.  Targeting the pH Paradigm at the Bedside: A Practical Approach.

Authors:  Tomas Koltai
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

Review 10.  Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How.

Authors:  Stefan Bröer
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

View more
  1 in total

1.  SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.

Authors:  Wenying Chen; Fengting Huang; Jing Huang; Yuanhua Li; Juanfei Peng; Yanyan Zhuang; Xianxian Huang; Liting Lu; Zhe Zhu; Shineng Zhang
Journal:  J Gene Med       Date:  2021-06-02       Impact factor: 4.565

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.